Prototype Analog Front-end for Negative-ion Gas and Dual-phase Liquid-Ar TPCs

We report on the recent development of a versatile analog front-end compatible with a negative-ion $\mu$-TPC for a directional dark matter search as well as a dual-phase, next-generation $\mathcal{O}$(10~kt) liquid argon TPC to study neutrino oscillations, nucleon decay, and astrophysical neutrinos. Although the operating conditions for negative-ion and liquid argon TPCs are quite different (room temperature \textit{vs.} $\sim$88~K operation, respectively), the readout electronics requirements are similar. Both require a wide-dynamic range up to 1600 fC, and less than 2000--5000 e$^-$ noise for a typical signal of 80 fC with a detector capacitance of $C_{\rm det} \approx 300$~pF. In order to fulfill such challenging requirements, a prototype ASIC was newly designed using 180-nm CMOS technology. Here, we report on the performance of this ASIC, including measurements of shaping time, dynamic range, and equivalent noise charge (ENC). We also demonstrate the first operation of this ASIC on a low-pressure negative-ion $\mu$-TPC.Comment: accepted by JINS

Precision mass measurements of magnesium isotopes and implications on the validity of the Isobaric Mass Multiplet Equation

If the mass excess of neutron-deficient nuclei and their neutron-rich mirror partners are both known, it can be shown that deviations of the Isobaric Mass Multiplet Equation (IMME) in the form of a cubic term can be probed. Such a cubic term was probed by using the atomic mass of neutron-rich magnesium isotopes measured using the TITAN Penning trap and the recently measured proton-separation energies of $^{29}$Cl and $^{30}$Ar. The atomic mass of $^{27}$Mg was found to be within 1.6$\sigma$ of the value stated in the Atomic Mass Evaluation. The atomic masses of $^{28,29}$Mg were measured to be both within 1$\sigma$, while being 8 and 34 times more precise, respectively. Using the $^{29}$Mg mass excess and previous measurements of $^{29}$Cl we uncovered a cubic coefficient of $d$ = 28(7) keV, which is the largest known cubic coefficient of the IMME. This departure, however, could also be caused by experimental data with unknown systematic errors. Hence there is a need to confirm the mass excess of $^{28}$S and the one-neutron separation energy of $^{29}$Cl, which have both come from a single measurement. Finally, our results were compared to ab initio calculations from the valence-space in-medium similarity renormalization group, resulting in a good agreement.Comment: 7 pages, 3 figure

Mass Measurement of 27^{27}P for Improved Type-I X-ray Burst Modeling

Light curves are the primary observable of type-I x-ray bursts. Computational x-ray burst models must match simulations to observed light curves. Most of the error in simulated curves comes from uncertainties in $rp$ process reaction rates, which can be reduced via precision mass measurements of neutron-deficient isotopes in the $rp$ process path. We perform a precise atomic mass measurement of $^{27}$P and use this new measurement to update existing type-I x-ray burst models to produce an improved light curve. High-precision Penning trap mass spectrometry was used to determine the atomic mass of $^{27}$P. Modules for Experiments in Stellar Astrophysics (MESA) was then used to simulate x-ray bursts using a 1D multi-zone model to produce updated light curves. The mass excess of $^{27}$P was measured to be -670.7$\pm$ 0.6 keV, a fourteen-fold precision increase over the mass reported in AME2020. The $^{26}$Si($p, \gamma$)$^{27}$P and reverse photodisintegration reaction rates have been determined to a higher precision based on the new, high precision mass measurement of $^{27}$P, and MESA light curves generated using these rates. Changes in the mass of $^{27}$P seem to have minimal effect on XRB light curves, even in burster systems tailored to maximize impact. The mass of $^{27}$P does not play a significant role in x-ray burst light curves. It is important to understand that more advanced models don't just provide more precise results, but often qualitatively different ones. This result brings us a step closer to being able to extract stellar parameters from individual x-ray burst observations. In addition, the Isobaric Multiplet Mass Equation (IMME) has been validated for the $A=27, T=3/2$ quartet, but only after including a small, theoretically predicted cubic term and utilizing an updated excitation energy for the $T=3/2$ isobaric analogue state of $^{27}$Si.Comment: 8 pages, 7 figure

Elevated serum neutrophil elastase is related to prehypertension and airflow limitation in obese women

<p>Abstract</p> <p>Background</p> <p>Neutrophil elastase level/activity is elevated in a variety of diseases such as atherosclerosis, systolic hypertension and obstructive pulmonary disease. It is unknown whether obese individuals with prehypertension also have elevated neutrophil elastase, and if so, whether it has a deleterious effect on pulmonary function. Objectives: To determine neutrophil elastase levels in obese prehypertensive women and investigate correlations with pulmonary function tests.</p> <p>Methods</p> <p>Thirty obese prehypertensive women were compared with 30 obese normotensive subjects and 30 healthy controls. The study groups were matched for age. Measurements: The following were determined: body mass index, waist circumference, blood pressure, lipid profile, high sensitivity C-reactive protein, serum neutrophil elastase, and pulmonary function tests including forced expiratory volume in one second (FEV₁), forced vital capacity (FVC) and FEV₁/FVC ratio.</p> <p>Results</p> <p>Serum neutrophil elastase concentration was significantly higher in both prehypertensive (405.8 ± 111.6 ng/ml) and normotensive (336.5 ± 81.5 ng/ml) obese women than in control non-obese women (243.9 ± 23.9 ng/ml); the level was significantly higher in the prehypertensive than the normotensive obese women. FEV1, FVC and FEV1/FVC ratio in both prehypertensive and normotensive obese women were significantly lower than in normal controls, but there was no statistically significant difference between the prehypertensive and normotensive obese women. In prehypertensive obese women, there were significant positive correlations between neutrophil elastase and body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low density lipoprotein cholesterol, high sensitivity C-reactive protein and negative correlations with high density lipoprotein cholesterol, FEV1, FVC and FEV1/FVC.</p> <p>Conclusion</p> <p>Neutrophil elastase concentration is elevated in obese prehypertensive women along with an increase in high sensitivity C-reactive protein which may account for dyslipidemia and airflow dysfunction in the present study population.</p

Recent Nuclear Astrophysics Measurements using the TwinSol Separator

Many astrophysical events, such as novae and X-ray bursts, are powered by reactions with radioactive nuclei. Studying the properties of these nuclei in the laboratory can therefore further our understanding of these astrophysical explosions. The TwinSol separator at the University of Notre Dame has recently been used to produce intense (∼106 pps) beams of 17F. In this article, some of the first measurements with these beams are discussed

Determining the \u3csup\u3e14\u3c/sup\u3eO(α,p)\u3csup\u3e17\u3c/sup\u3eF astrophysical rate from Measurements at TwinSol

The 14O(α,p)17F reaction is an important trigger reaction to the α-p process in X-ray bursts. The most stringent experimental constraints on its astrophysical rate come from measurements of the time-inverse reaction, 17F(p,α)14O. Previous studies of this inverse reaction have sufficiently characterized the high-energy dependence of the cross section but there are still significant uncertainties at lower energies. A new measurement of the 17F(p,α)14O cross section is underway at the Twin Solenoid (TwinSol) facility at the University of Notre Dame using an in-flight secondary 17F beam. The initial results are promising but improvements are needed to complete the measurement. The initial data and plans for an improved measurement are presented in this manuscript

Sterility and Gene Expression in Hybrid Males of Xenopus laevis and X. muelleri

BACKGROUND: Reproductive isolation is a defining characteristic of populations that represent unique biological species, yet we know very little about the gene expression basis for reproductive isolation. The advent of powerful molecular biology tools provides the ability to identify genes involved in reproductive isolation and focuses attention on the molecular mechanisms that separate biological species. Herein we quantify the sterility pattern of hybrid males in African Clawed Frogs (Xenopus) and apply microarray analysis of the expression pattern found in testes to identify genes that are misexpressed in hybrid males relative to their two parental species (Xenopus laevis and X. muelleri). METHODOLOGY/PRINCIPAL FINDINGS: Phenotypic characteristics of spermatogenesis in sterile male hybrids (X. laevis x X. muelleri) were examined using a novel sperm assay that allowed quantification of live, dead, and undifferentiated sperm cells, the number of motile vs. immotile sperm, and sperm morphology. Hybrids exhibited a dramatically lower abundance of mature sperm relative to the parental species. Hybrid spermatozoa were larger in size and accompanied by numerous undifferentiated sperm cells. Microarray analysis of gene expression in testes was combined with a correction for sequence divergence derived from genomic hybridizations to identify candidate genes involved in the sterility phenotype. Analysis of the transcriptome revealed a striking asymmetric pattern of misexpression. There were only about 140 genes misexpressed in hybrids compared to X. laevis but nearly 4,000 genes misexpressed in hybrids compared to X. muelleri. CONCLUSIONS/SIGNIFICANCE: Our results provide an important correlation between phenotypic characteristics of sperm and gene expression in sterile hybrid males. The broad pattern of gene misexpression suggests intriguing mechanisms creating the dominance pattern of the X. laevis genome in hybrids. These findings significantly contribute to growing evidence for allelic dominance in hybrids and have implications for the mechanism of species differentiation at the transcriptome level

Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B

© 2020 The Authors. Published by Springer. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1038/s41467-020-18668-2A phenotype of Escherichia coli and Klebsiella pneumoniae, resistant to piperacillin/tazobactam (TZP) but susceptible to carbapenems and 3rd generation cephalosporins, has emerged. The resistance mechanism associated with this phenotype has been identified as hyperproduction of the β-lactamase TEM. However, the mechanism of hyperproduction due to gene amplification is not well understood. Here, we report a mechanism of gene amplification due to a translocatable unit (TU) excising from an IS26-flanked pseudo-compound transposon, PTn6762, which harbours blaTEM-1B. The TU re-inserts into the chromosome adjacent to IS26 and forms a tandem array of TUs, which increases the copy number of blaTEM-1B, leading to TEM-1B hyperproduction and TZP resistance. Despite a significant increase in blaTEM-1B copy number, the TZP-resistant isolate does not incur a fitness cost compared to the TZP-susceptible ancestor. This mechanism of amplification of blaTEM-1B is an important consideration when using genomic data to predict susceptibility to TZP.This work was supported by the Liverpool School of Tropical Medicine Director’s Catalyst Fund awarded to A.T.M.H. and T.E. A.P.R. would like to acknowledge funding from the AMR Cross-Council Initiative through a grant from the Medical Research Council, a Council of UK Research and Innovation (Grant number; MR/S004793/1), and funding from the National Institute for Health Research. (Grant Number; NIHR200632).Published versio